SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-016638
Filing Date
2019-05-07
Accepted
2019-05-07 17:27:03
Documents
54
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q apls-10q_20190331.htm 10-Q 1470863
2 EX-10.1 apls-ex101_221.htm EX-10.1 583329
3 EX-10.2 apls-ex102_113.htm EX-10.2 690388
4 EX-10.3 apls-ex103_168.htm EX-10.3 26216
5 EX-31.1 apls-ex311_8.htm EX-31.1 18211
6 EX-31.2 apls-ex312_7.htm EX-31.2 17555
7 EX-32.1 apls-ex321_9.htm EX-32.1 8567
8 EX-32.2 apls-ex322_6.htm EX-32.2 8576
9 GRAPHIC gkurtgndusz3000001.jpg GRAPHIC 98445
  Complete submission text file 0001564590-19-016638.txt   4834095

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT apls-20190331.xml EX-101.INS 306704
11 XBRL TAXONOMY EXTENSION SCHEMA apls-20190331.xsd EX-101.SCH 33322
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE apls-20190331_cal.xml EX-101.CAL 42569
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE apls-20190331_def.xml EX-101.DEF 83766
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE apls-20190331_lab.xml EX-101.LAB 257216
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apls-20190331_pre.xml EX-101.PRE 185493
Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014 502-241-4114
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38276 | Film No.: 19804290
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences